IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Cambrex’s Fourth-Quarter Loss Widens

10:27 PM MST | February 11, 2010 | Deepti Ramesh

Cambrex (East Rutherford, NJ) reported a net loss of $2.8 million for the fourth quarter of 2009, compared with a net loss of about $1 million in the fourth quarter of 2008. Net sales decreased by nearly 10%, to $57.9 million. The fall in sales, was mainly due to lower volumes of an active pharmaceutical ingredient (API) that utilizes Cambrex’s polymeric drug delivery technology, lower sales of two APIs manufactured under long-term supply agreements and lower custom development revenues, Cambrex says. Volumes of a feed additive for which a contract expired...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa